Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
Developing IQVIA’s positions on key trends in the pharma and life sciences industries, with a focus on EMEA.
Learn more
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Artificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBS
The next decade will see greater concentration of competition for innovative Launches, with focus turning to more specialist therapy areas, limited key launch countries, healthcare budgets, doctor attention time, and even patients. Achieving true Launch Excellence will become even more challenging. To understand how to succeed in the future, companies must first understand how today’s launch environment drivers came to be.
Ten years ago, IMS Health (now IQVIA) published a white paper entitled “Launch Excellence”. It defined objective criteria for excellence in launch for prescription medicines and developed in-depth insight on medicines that achieved them. We drew tough but surprising conclusions. For example, that the first six months has a disproportionate influence on later success for at least 80% of launches in any country.
New Chemical Entity launch success is still, overwhelmingly, a developed markets game: 86% of the first five years’ sales of New Chemical Entities launches since 2005 came from just seven countries: the U.S., Japan, Germany, France, UK, Spain and Italy. Our interviews with companies preparing for launch suggest the overwhelming majority, if asked, will classify themselves as “behind” on some or all aspects of their launch preparation. But some of these companies will go on to have excellent launches — others will not. Quality of preparation matters as well as quantity.
Launch Excellence is at the heart of many of the fundamental changes in the pharmaceutical industry’s landscape. Launches drive pharmaceutical industry change, so excellence in launch is the key to the pharmaceutical industry’s future.
The first Launch Excellence white paper analysed launches back to 1995, an almost Jurassic era when the big beasts of the pharmaceutical launch world were primary care, mass market products: Lipitor, Plavix, Seretide, or Detrusitol.
Use a web-based platform to identify crucial pre-launch activities, create and monitor launch plans across your entire global portfolio across different markets
Assess and enhance launch preparations. Optimize launch execution.
Launch with confidence and excellence the first time.
